From Clinicaltrials.gov
Study Type: Interventional (Clinical Trial)
Estimated Enrollment :44 participants
Allocation:N/A
Intervention Model:Single Group Assignment
Masking:None (Open Label)
Primary Purpose:Treatment
Official Title:A Phase I/Ib Open-Label, Multi-Center, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics and Preliminary Efficacy of Intravenous NBF 006 in Patients With Non-Small Cell Lung, Pancreatic, or Colorectal Cancer Followed by a Dose Expansion Study in Patients With KRAS-Mutated Non-Small Cell Lung Cancer